Board Meeting14 Aug 2026, 08:40 pm
Aarey Drugs Declares Unaudited Q1 FY27 Results
AI Summary
Aarey Drugs & Pharmaceuticals Ltd announced its unaudited financial results for the first quarter ended June 30, 2026. The Board of Directors approved these results, along with the Limited Review Report and MD/CFO certification. A statement on deviation or variation in the utilization of funds raised through convertible warrants (preferential issue) was also considered and approved. The company confirmed its single business segment. The trading window will reopen 48 hours after the announcement of these results.
Key Highlights
- Unaudited financial results for Q1 FY27 declared.
- Board approved results and limited review report.
- Statement on fund utilization from warrants considered.
- Trading window to reopen post-announcement.
Price Impact
More from AAREYDRUGS